Panitumumab and Bortezomib for Patients With Advanced Colorectal Cancer
收藏NIAID Data Ecosystem2026-03-07 收录
官方服务：
资源简介：
Panitumumab plus bortezomib for colon cancer
应用场景：
创建时间：
2011-12-15
相关数据集
Phase II Study of GW786034 in Patients With Relapsed or Refractory Soft Tissue Sarcoma
The purpose of this study is to evaluate the activity and tolerability of pazopanib in subjects with advanced and/or metastatic soft tissue sarcoma who have relapsed following standard therapies or fo
DataCite Commons2025-12-16 更新70
Sorafenib With Irinotecan in Metastatic Colorectal Cancer (mCRC) and K-RAS Mutation
A multicentre two-part phase I/II study evaluating response and safety of SORAFENIB in combination with irinotecan in the second line treatment or more of metastatic colorectal cancer with K-RAS mutat
NIAID Data Ecosystem40
Supplementary Table 5 from PIK3CA Mutations Contribute to Acquired Cetuximab Resistance in Patients with Metastatic Colorectal Cancer
Dynamics of mutations related to acquired resistance in validation cohort
NIAID Data Ecosystem30
Study of Bevacizumab Plus Chemotherapy in Patients With Metastatic Colorectal Cancer
This study evaluates the relationship of biomarker expression and efficacy of bevacizumab plus chemotherapy in patients with unresectable/metastatic colorectal cancer. Before the treatment, the invest
NIAID Data Ecosystem60
Table S1 - Heterogeneous EGFR Gene Copy Number Increase Is Common in Colorectal Cancer and Defines Response to Anti-EGFR Therapy
Tumor response and survival of patients with chemorefractory KRAS wild type metastatic or locally advanced colorectal cancer treated with cetuximab or panitumumab according to EGFR Gene Copy Number. (
Figshare2015-12-02 更新30
